TTN non-truncating variants in DCM cohorts


The table below lists the 70 rare (MAF<0.0001 in ExAC) non-truncating TTN variants identified in a cohort of 156 DCM patients. When this rare variant frequency of 0.44870 is compared with a background population rate of 0.39200, there is a statistically significant case excess of 0.05670 (p<0.0001), which suggests that approximately of these variants may be pathogenic.


Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (156)LMM class ExAC frequency
1. c.37432C>T p.P12478Smissense 2VUS0.000000
2. c.98296G>T p.D32766Ymissense 1VUS0.000008
3. c.9674A>G p.N3225Smissense 1VUS0.000024
4. c.102638A>G p.N34213Smissense 1VUS0.000008
5. c.105630A>C p.Gln35210Hismissense 1VUS0.000000
6. c.98243G>A p.R32748Hmissense 1VUS0.000066
7. c.50647C>T p.Pro16883Sermissense 1VUS0.000000
8. c.39163A>G p.Lys13055Glumissense 1VUS0.000000
9. c.63632T>C p.Val21211Alamissense 1VUS0.000000
10. c.58684A>G p.Ile19562Valmissense 1VUS0.000000
11. c.67147G>A p.G22383Rmissense 1VUS0.000058
12. c.6941T>C p.I2314Tmissense 1VUS0.000008
13. c.5132C>T p.S1711Fmissense 1VUS0.000016
14. c.12037G>A p.Ala4013Thrmissense 1VUS0.000000
15. c.20742T>A p.Phe6914Leumissense 1VUS0.000000
16. c.99434G>A p.R33145Qmissense 1VUS0.000033
17. c.18663A>C p.E6221Dmissense 1VUS0.000099
18. c.102428T>C p.M34143Tmissense 1VUS0.000074
19. c.93968C>T p.A31323Vmissense 1VUS0.000057
20. c.22386T>G p.Asp7462Glumissense 1VUS0.000000
21. c.28754A>C p.Glu9585Alamissense 1VUS0.000000
22. c.57415A>C p.Ile19139Leumissense 1VUS0.000000
23. c.54091A>G p.S18031Gmissense 1VUS0.000008
24. c.62290G>C p.Glu20764Glnmissense 1VUS0.000000
25. c.64903C>T p.R21635Cmissense 1VUS0.000024
26. c.89947G>A p.V29983Mmissense 1VUS0.000099
27. c.6029A>G p.Y2010Cmissense 1VUS0.000008
28. c.3469G>A p.V1157Imissense 1VUS0.000041
29. c.80608C>A p.Pro26870Thrmissense 1VUS0.000000
30. c.96140C>T p.T32047Mmissense 1VUS0.000057
31. c.5582G>A p.R1861Hmissense 1VUS0.000082
32. c.11140A>G p.Ile3714Valmissense 1VUS0.000000
33. c.26765G>A p.Arg8922Glnmissense 1VUS0.000000
34. c.19015T>C p.Tyr6339Hismissense 1VUS0.000000
35. c.24344G>A p.S8115Nmissense 1VUS0.000083
36. c.39749_39766delTTGCTCCTGAAGAGGAAA inframe 1VUS0.000000
37. c.47887A>G p.M15963Vmissense 1VUS0.000033
38. c.68272G>A p.D22758Nmissense 1VUS0.000026
39. c.54685G>A p.V18229Mmissense 1VUS0.000091
40. c.58705G>A p.D19569Nmissense 1VUS0.000017
41. c.1186G>A p.A396Tmissense 1VUS0.000008
42. c.78980G>A p.R26327Qmissense 1VUS0.000049
43. c.74527A>G p.N24843Dmissense 1VUS0.000033
44. c.91478A>G p.Glu30493Glymissense 1VUS0.000000
45. c.94629A>G p.I31543Mmissense 1VUS0.000066
46. c.99814C>T p.L33272Fmissense 1VUS0.000009
47. c.105590G>A p.G35197Dmissense 1VUS0.000041
48. c.25046C>G p.A8349Gmissense 1VUS0.000008
49. c.15369_15371delGTT inframe 1VUS - favor pathogenic0.000000
50. c.54167G>A p.R18056Qmissense 1VUS0.000026
51. c.62780G>A p.R20927Hmissense 1VUS0.000008
52. c.77816A>C p.Asp25939Alamissense 1VUS0.000000
53. c.72985A>G p.Asn24329Aspmissense 1VUS0.000000
54. c.70181C>T p.T23394Mmissense 1VUS0.000024
55. c.6478A>G p.T2160Amissense 1VUS0.000016
56. c.85195G>A p.E28399Kmissense 1VUS0.000016
57. c.89766G>C p.Lys29922Asnmissense 1VUS0.000000
58. c.96286G>A p.A32096Tmissense 1VUS0.000066
59. c.93472G>C p.Asp31158Hismissense 1VUS0.000000
60. c.20260A>G p.Lys6754Glumissense 1VUS0.000000
61. c.11450G>A p.G3817Dmissense 1VUS0.000017
62. c.107285G>A p.R35762Qmissense 1VUS0.000033
63. c.43019T>C p.I14340Tmissense 1VUS0.000008
64. c.48395G>A p.R16132Hmissense 1VUS0.000066
65. c.58982G>A p.G19661Dmissense 1VUS0.000016
66. c.55139T>C p.I18380Tmissense 1VUS0.000050
67. c.72488G>A p.R24163Hmissense 1VUS0.000054
68. c.84523T>C p.Trp28175Argmissense 1VUS0.000000
69. c.2605A>T p.T869Smissense 1VUS0.000041

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, Bowser M, Harrison B, Aaron D, Mahanta LM, Lakdawala NK, McDermott G, White ET, Rehm HL, Lebo M, Funke BH. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014 Aug;16(8):601-8.